NCT04485013 2026-02-18TTX-080 HLA-G Antagonist in Subjects With Advanced CancersTizona Therapeutics, IncPhase 1 Recruiting240 enrolled
NCT06764771 2025-12-17A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant TumorsBristol-Myers SquibbPhase 1 Active not recruiting437 enrolled
NCT01552434 2025-10-14Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseM.D. Anderson Cancer CenterPhase 1 Active not recruiting155 enrolled
NCT00622674 2017-12-02Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed37 enrolled